Abionyx Pharma SA banner

Wall St Price Targets

0RAG Price Forecast
Based on 4 analysts

+565% Upside
from €1.51 today

Abionyx Pharma SA (0RAG)’s 12-month stock price forecast through November 2027 has a consensus target of €10.04, implying 565% upside. The forecast is based on price targets from 4 Wall Street analysts.

0RAG Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 0RAG yet.

Abionyx Pharma SA Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0RAG's stock price target?
Price Target
10.04 EUR

According to Wall Street analysts, the average 1-year price target for 0RAG is 10.04 EUR with a low forecast of 8.45 EUR and a high forecast of 11.2 EUR.

What is the Revenue forecast for Abionyx Pharma SA?
Projected CAGR
112%

The compound annual growth rate for Revenue over the next 3 years is 112%.

What is the Gross Profit forecast for Abionyx Pharma SA?
Projected CAGR
24%

The compound annual growth rate for Gross Profit over the next 2 years is 24%.

Back to Top